The ion channel known as the calcium channel exhibits selective permeability to calcium ions. Although there are ligand-gated calcium channels as well, it is sometimes referred to as a voltage-dependent calcium channel. Even though the concentration of Na+ outside of cells is 70 times higher than that of Ca2+, voltage-gated calcium (CaV) channels catalyze a rapid, highly selective influx of Ca2+ into cells. A side effect of some calcium channel blockers is that they slow your heart rate, which helps to lower blood pressure, treat angina, and regulate irregular heartbeats.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V87786 | ANO61 | 940476-20-0 | ANO61 is a dibenzylformamide derivative that exerts antiplatelet aggregation effects by modulating thrombin-induced Ca2+ responses with an IC50 of 47.7 μM. |
|
V77980 | Azelnidipine-d7 (Azelnidipine D7; CS-905-d7) | Azelnidipine-d7 is the deuterium labelled form of Azelnidipine. | |
|
V89927 | Azumolene sodium | 105336-14-9 | Azumolene sodium (EU4093) is a dantrolene analog that inhibits Halothane/Succinylcholine-induced malignant hyperthermia (MH) syndrome and intracellular Ca2+ homeostasis failure. |
|
V78345 | Barnidipine-d5 hydrochloride (Mepirodipine-d5 hydrochloride; YM-09730-5-d5 hydrochloride) | Barnidipine-d5 ( HCl) is the deuterated form of Barnidipine HCl. | |
|
V71473 | Bepridil hydrochloride hydrate ((±)-Bepridil hydrochloride hydrate; Org 5730 hydrochloride hydrate) | 74764-40-2 | Bepridil HCl hydrate ((±)-Bepridil HCl hydrate) is a non-selective, long-acting calcium ion channel (Ca+ channel) antagonist, sodium ion, potassium ion channel (Na+, K+ channel) inhibitor, with anti-angina and anti-anginal properties. |
|
V78576 | Butamben-d9 (Butyl 4-aminobenzoate-d9) | Butamben-d9 is the deuterated form of Butamben. | |
|
V98442 | CAD204520 | 2682205-20-3 | CAD204520 is an inhibitor of SERCA (IC50 = 0.34 μM) against T-cell acute lymphoblastic leukemia (T-ALL) and marginal zone cell lymphoma (MCL) with wild-type NOTCH1 protein mutations. |
|
V71540 | Calciceptin | 178805-91-9 | Calciceptine, a natural neurotoxin extracted from the black mamba Dendroaspis p. polylepis. |
|
V71492 | Calcicludine | 178036-64-1 | Calcicludine is a protein toxin derived from the venom of the green mamba snake Dendroaspis angusticeps. |
|
V71541 | Calcium Channel antagonist 2 | 874370-15-7 | Calcium Channel antagonist 2 (Compound 154) is a calcium channel antagonist (IC50=5-20 μM), which can be used for Ca2+ channel-mediated diseases, such as pain and diabetes. |
|
V71522 | Calcium Channel antagonist 3 | 687573-14-4 | Calcium Channel antagonist 3 (compound 397) is a voltage-gated calcium channel inhibitor (antagonist) with IC50 of 5-20μM. |
|
V71495 | Calcium Channel antagonist 4 | 687574-49-8 | Calcium Channelantagonist 4 (compound 189) is a voltage-gated calcium channel inhibitor (antagonist) with IC50 of 5-20μM. |
|
V106714 | Calcium Channel antagonist 5 | 21829-09-4 | Calcium channel antagonist 5 (Compound 32) is a calcium channel antagonist with a pIC50 of 5.50. |
|
V89033 | Calcium citrate tetrahydrate, 99% | 5785-44-4 | Calcium citrate tetrahydrate, 99% can release calcium ions in a short period of time, and can obtain highly active and high-concentration calcium ions, thereby stimulating bone formation. |
|
V104807 | Calcium influx inducer compound 634 | 882291-37-4 | Calcium influx inducer Compound 634 is a calcium influx inducer. |
|
V78613 | Caloxin 3A1 | Caloxin 3A1 is a biologically active peptide. | |
|
V99631 | Calpain-1, Human Erythrocyte | Human erythrocyte calpain-1 is an intracellular Ca2+-regulated cysteine protease. | |
|
V71504 | Catharanthine Sulfate (vinblastine sulfate; (+)-3,4-Didehydrocoronaridine Sulfate) | 153230-94-5 | Catharanthine Sulfate ((+)-3,4-Didehydrocoronaridine Sulfate) is an alkaloid in Catharanthus roseus. |
|
V103481 | Cav 3.1 blocker 1 | 2158201-04-6 | Cav 3.1 blocker 1 (compound 12) is a T-type calcium channel blocker with IC50 of 160 nM for Cav3.1, weak inhibitory effect on Cav 3.2 (IC50 of 5000 nM), and no inhibitory effect on Cav 3.3 and Cav 1.2 (IC50 >10000 nM). |
|
V71525 | Cav 3.2 inhibitor 1 | 2878598-59-3 | Cav 3.2 inhibitor 1 is a T-type calcium channel inhibitor (antagonist) with low binding affinity to dopamine receptor (D2 receptor). |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
